Topical Skin Adhesive Sales

Topical Skin Adhesive Sales Market Outlook

The global topical skin adhesive market is projected to reach approximately USD 4.2 billion by 2035, growing at a remarkable CAGR of 8.6% from 2025 to 2035. This growth trajectory is primarily driven by the increasing demand for advanced wound management solutions and the rising prevalence of surgical procedures worldwide. Additionally, the convenience and effectiveness of topical skin adhesives over traditional sutures are attracting more healthcare professionals and patients. The growing geriatric population, coupled with increasing incidences of chronic wounds and trauma, further propels this market. Moreover, technological advancements and innovations in adhesive formulations are expected to create new opportunities, enhancing the overall market landscape.

Growth Factor of the Market

The topical skin adhesive market is experiencing significant growth due to several factors. One of the foremost drivers is the increasing number of surgical procedures performed annually, which necessitates the use of reliable wound closure methods. Furthermore, the shift towards minimally invasive surgical techniques has led to a growing preference for adhesives, as they reduce the risk of infection and promote faster healing. The rising awareness regarding the advantages of topical adhesives, including ease of use, reduced scarring, and minimal discomfort, is propelling demand in both clinical and at-home settings. Additionally, advancements in adhesive technology, such as the development of biocompatible and bioresorbable formulations, have enhanced the safety and efficacy of these products. Finally, the rising prevalence of chronic wounds stemming from diabetes and other health conditions is further boosting market growth.

Key Highlights of the Market

• Strong growth in the surgical procedures segment, enhancing the demand for topical adhesives.
• Technological advancements leading to the development of innovative adhesive formulations.
• Increased focus on minimally invasive techniques within surgical environments.
• Growing awareness about the benefits of topical adhesives compared to traditional sutures.
• Rising geriatric population vulnerable to wounds, driving market adoption.

By Product Type

Cyanoacrylate-based Adhesives:

Cyanoacrylate-based adhesives are among the most widely utilized topical skin adhesives due to their rapid bonding capabilities and strong adhesive properties. These adhesives polymerize quickly upon contact with moisture, forming a robust bond that effectively closes wounds. Their application spans various medical fields, including surgical procedures and trauma care. Cyanoacrylate adhesives are especially favored in emergency settings where expedient closure is paramount. Moreover, advancements in formulation have led to the development of medical-grade cyanoacrylate adhesives that are safer for skin application, thus widening their usage in everyday clinical practices.

Fibrin-based Adhesives:

Fibrin-based adhesives hold significant relevance in surgical applications, particularly in areas requiring hemostasis. Derived from human fibrinogen and thrombin, these adhesives mimic the natural clotting process, facilitating wound closure and promoting healing. Their biological compatibility makes them ideal for use in sensitive tissues, reducing the risk of adverse reactions. Fibrin-based adhesives are extensively used in cardiovascular, orthopedic, and general surgery, where effective bleeding control is crucial. The ability of these adhesives to promote cellular infiltration and tissue regeneration further enhances their appeal in complex surgical procedures.

Collagen-based Adhesives:

Collagen-based adhesives are gaining traction due to their biocompatibility and bioactivity. As a natural protein found in the human body, collagen serves as an excellent substrate for cellular adhesion and tissue repair. These adhesives are particularly useful in dermatological applications and regenerative medicine, where they facilitate wound healing by promoting cell proliferation and migration. Healthcare professionals increasingly prefer collagen-based adhesives for their ability to integrate seamlessly with natural tissue, thereby enhancing recovery outcomes. Their use in treating chronic wounds and skin injuries further highlights their growing significance in the topical adhesive market.

Albumin-based Adhesives:

Albumin-based adhesives are another emerging product type in the topical adhesive market. Known for their excellent adhesion properties and biological safety, these adhesives are derived from human serum albumin, making them biocompatible. Their application is particularly prevalent in surgical wound closure and tissue repair, where they help in sealing incisions effectively. The versatility of albumin-based adhesives makes them suitable for various surgical specialties, including plastic surgery and ophthalmology. The ability of these adhesives to facilitate the healing process while minimizing inflammation underscores their utility in modern medical practices.

Gelatin-based Adhesives:

Gelatin-based adhesives are increasingly being adopted in the medical field due to their natural origin and favorable biocompatibility. These adhesives are derived from collagen and exhibit excellent adhesion properties, making them suitable for a variety of wound closure applications. Gelatin-based adhesives are particularly beneficial for use in sensitive tissues, where gentle application is required. Their biodegradability and non-toxic nature further enhance their appeal, as they minimize the risk of adverse reactions. The potential for gelatin-based adhesives to support the healing process and reduce scarring makes them a preferred choice for both surgical and cosmetic procedures.

By Application

Surgical Procedures:

Surgical procedures represent a key application segment for topical skin adhesives, as they provide an efficient and effective method for wound closure. Topical adhesives offer several advantages over traditional sutures, including faster application, reduced risk of infection, and less postoperative pain. These adhesives are utilized in diverse surgical fields, including general surgery, orthopedic procedures, and plastic surgery. Their ability to bond quickly and securely allows for improved patient outcomes and satisfaction. Additionally, the growing trend towards minimally invasive surgeries further drives demand for topical adhesives in surgical environments.

Trauma Wound Care:

Trauma wound care is another significant application area for topical skin adhesives. With the increasing incidence of accidents and injuries, the demand for efficient wound closure solutions has surged. Topical adhesives provide a fast and effective means to close lacerations and abrasions, minimizing the risk of infection and promoting healing. Their ease of use enables healthcare personnel to apply them quickly in emergency situations, making them a vital component of trauma care. Furthermore, the growing awareness of the benefits of topical adhesives in managing trauma wounds is expected to bolster this segment's growth in the coming years.

Burn Injury Care:

Burn injury care is a critical application for topical skin adhesives due to their suitability for managing complex wounds. Topical adhesives can be utilized to close superficial burns and enhance the healing process by providing a protective barrier against external pathogens. They reduce the risk of scarring and promote faster recovery, making them an essential component of burn management protocols. The increasing prevalence of burn injuries, often resulting from household accidents or industrial mishaps, drives the demand for effective wound closure solutions like topical adhesives. As healthcare professionals seek to improve patient outcomes, the role of topical adhesives in burn injury care is likely to expand.

Others:

In addition to surgical procedures, trauma wound care, and burn injury care, various other applications for topical skin adhesives exist. These include their use in cosmetic procedures, dermatological treatments, and even veterinary applications. The versatility of topical adhesives allows for their use across a wide range of medical scenarios, enhancing their market potential. As the medical community continues to explore innovative applications for topical adhesives, their adoption in newer areas such as regenerative medicine and aesthetic treatments is anticipated to grow. The ability to offer effective wound closure while minimizing pain and scarring positions topical adhesives favorably across numerous applications.

By Distribution Channel

Hospitals:

Hospitals serve as a primary distribution channel for topical skin adhesives, given their extensive use in surgical and emergency care settings. The ability to provide immediate access to a wide range of adhesive products makes hospitals a focal point for the application of topical adhesives. With a growing emphasis on patient safety and outcomes, healthcare facilities are increasingly adopting advanced wound management protocols that incorporate topical adhesives. The presence of trained medical professionals ensures the appropriate selection and application of these adhesives, further driving their utilization in hospitals. As surgical procedures continue to rise, the role of hospitals in the topical adhesive market is projected to expand.

Specialty Clinics:

Specialty clinics represent a significant distribution channel for topical skin adhesives, especially in areas such as dermatology, plastic surgery, and wound care. These clinics often focus on specific medical fields that require advanced wound management solutions. The targeted nature of specialty clinics allows for a more tailored approach to adhesive application, ensuring optimal patient outcomes. Furthermore, the increasing number of specialty clinics focused on outpatient care is enhancing the availability of topical adhesives in diverse medical settings. The growing trend towards individualized patient care and minimally invasive procedures positions specialty clinics as key players in the topical adhesive market.

Ambulatory Surgical Centers:

Ambulatory surgical centers (ASCs) are becoming increasingly important in the distribution of topical skin adhesives. With the rise in outpatient surgical procedures, ASCs offer a convenient and efficient setting for wound closure using topical adhesives. The ability to perform surgeries and provide immediate post-operative care in one location makes ASCs a preferred choice for both clinicians and patients. Topical adhesives are favored in ASCs due to their quick application and effectiveness, allowing for enhanced patient throughput. The growth of ASCs in the healthcare landscape is expected to significantly contribute to the expansion of the topical adhesive market.

Retail Pharmacies:

Retail pharmacies are emerging as a vital distribution channel for topical skin adhesives, catering to the increasing demand for at-home wound care solutions. The convenience of purchasing topical adhesives over the counter enables patients to manage minor wounds and lacerations without the need for immediate medical intervention. Retail pharmacies are stocking a variety of adhesive products, including those suitable for everyday injuries and cosmetic applications. The growing consumer awareness regarding the benefits of topical adhesives has led to increased sales in retail settings. As more individuals seek efficient wound care solutions, the role of retail pharmacies in the topical adhesive market is likely to grow.

By Ingredient Type

2-Octyl Cyanoacrylate:

2-Octyl cyanoacrylate is a popular ingredient in topical skin adhesives, known for its superior bonding strength and flexibility. This formulation is particularly effective in surgical applications, where it provides a secure seal while allowing for normal movement of the skin. Its biocompatibility makes it suitable for a variety of skin types, reducing the risk of irritation or allergic reactions. Healthcare professionals favor 2-octyl cyanoacrylate for its ease of application and rapid drying time, which enhances patient comfort during procedures. The increasing adoption of this ingredient in both surgical and cosmetic applications is anticipated to drive its market growth.

N-Butyl Cyanoacrylate:

N-butyl cyanoacrylate is another significant ingredient type used in topical skin adhesives. It is known for its strong bonding properties and is frequently employed in surgical environments where rapid closure is essential. This ingredient provides a robust solution for closing wounds, minimizing the risk of infection and promoting quicker healing. N-butyl cyanoacrylate is particularly beneficial in pediatric applications, as it offers a gentle yet effective means of wound closure. The versatility of this ingredient makes it suitable for a range of surgical procedures, thus enhancing its demand within the market.

Human Fibrinogen:

Human fibrinogen is a critical component in fibrin-based adhesives, serving as a natural substrate for wound healing. Its use in topical skin adhesives is particularly relevant in surgical procedures where hemostasis is necessary. Fibrinogen promotes the formation of a stable clot, facilitating tissue repair and regeneration. The biocompatibility of human fibrinogen ensures that adhesives developed with this ingredient are safe for use in sensitive areas of the body. As the demand for effective and biocompatible wound closure solutions grows, the use of human fibrinogen in adhesives is expected to expand significantly.

Human Thrombin:

Human thrombin is another key ingredient in topical skin adhesives, particularly in applications requiring rapid hemostasis. Its primary role is to catalyze the conversion of fibrinogen to fibrin, forming a stable clot that enhances wound closure. The incorporation of thrombin into adhesive formulations improves their efficacy in surgical and trauma settings, providing a dual function of closure and hemostasis. The safety of human thrombin for use in medical applications makes it a preferred choice for healthcare professionals. The increasing focus on minimizing surgical complications and enhancing patient recovery is likely to drive the demand for thrombin-based adhesives.

Collagen:

Collagen is a fundamental ingredient in various topical skin adhesives, known for its natural origin and excellent biocompatibility. Its role in promoting cellular adhesion and tissue regeneration makes collagen-based adhesives particularly valuable in wound care and surgical applications. These adhesives not only facilitate effective wound closure but also support the healing process by fostering cell migration and proliferation. The growing emphasis on natural and biocompatible materials in medical applications is propelling the demand for collagen-based adhesives. As healthcare providers seek effective solutions for chronic wounds and surgical incisions, collagen's importance in the market is expected to increase.

By Region

The North American region is anticipated to dominate the topical skin adhesive market, accounting for over 35% of the global market share by 2035. This dominance can be attributed to the high volume of surgical procedures, coupled with strong healthcare infrastructure and advanced medical technology adoption. The prevalence of chronic diseases and an aging population further drive the demand for effective wound management solutions in this region. Moreover, the increasing emphasis on minimizing postoperative complications is promoting the adoption of topical adhesives in surgical settings. The North American market is projected to grow at a CAGR of 8.0% during the forecast period, underscoring its significant role in the global market.

In Europe, the topical skin adhesive market is also witnessing substantial growth, with a projected share of around 30% by 2035. A rise in regulatory approvals for advanced adhesive formulations and an increasing focus on wound care management are key factors driving this growth. Countries such as Germany, the UK, and France are leading contributors to the market, supported by their well-established healthcare systems and high adoption rates of innovative medical technologies. As healthcare providers continue to seek efficient and effective wound closure methods, the European market is expected to grow at a CAGR of 7.5% during the forecast period, further reinforcing its significance in the global landscape.

Opportunities

As the topical skin adhesive market continues to evolve, several opportunities are emerging for manufacturers and healthcare providers. One significant opportunity lies in the development of innovative adhesive formulations that leverage advancements in materials science and biotechnology. This includes exploring bioresorbable adhesives that can dissolve naturally in the body, reducing the need for removal procedures and minimizing patient discomfort. Additionally, the integration of smart technologies into topical adhesives—such as sensors that monitor wound healing—presents a promising avenue for innovation. As patients and healthcare institutions increasingly seek solutions that enhance treatment outcomes, the push for advanced adhesive products is likely to gain momentum.

Moreover, expanding the application of topical skin adhesives beyond traditional surgical uses presents lucrative opportunities. For instance, the growing interest in cosmetic procedures and aesthetic treatments has opened new markets for topical adhesives designed specifically for skin applications. Similarly, the increasing incidence of chronic wounds, driven by conditions such as diabetes and obesity, necessitates effective wound management solutions. By tailoring products to meet the specific needs of diverse patient populations and clinical settings, manufacturers can capture a broader market share. The potential for collaboration between adhesive manufacturers and healthcare providers also presents opportunities for enhancing product development and education regarding effective adhesive use.

Threats

Despite its promising growth trajectory, the topical skin adhesive market faces several threats that could hinder its progress. One major concern is the increasing competition among manufacturers, leading to price wars and reduced profit margins. As more players enter the market, the risk of product commoditization becomes higher, potentially affecting the quality of adhesive products. Additionally, regulatory challenges and stringent approval processes for new adhesive formulations can slow down product development and market entry. The need for comprehensive clinical evidence to support the efficacy and safety of topical adhesives places additional pressure on manufacturers to invest in research and development, further complicating market dynamics.

Furthermore, the potential for adverse reactions to topical adhesives poses a threat to market growth. Although most modern adhesives are designed to be biocompatible, there remains a risk of allergic reactions or skin irritation, which can lead to negative patient experiences. Such incidents could deter healthcare providers from adopting topical adhesives, particularly in sensitive patient populations. The increasing focus on evidence-based practices in healthcare may also compel clinicians to favor traditional wound closure methods over topical adhesives, posing a challenge to market expansion. Manufacturers must address these threats by ensuring the safety and effectiveness of their products while fostering strong relationships with healthcare providers to gain their trust and support.

Competitor Outlook

• 3M Company
• Baxter International Inc.
• Ethicon, Inc. (subsidiary of Johnson & Johnson)
• Medtronic plc
• West Pharmaceutical Services, Inc.
• Adhezion Biomedical, LLC
• Smith & Nephew plc
• SuperGlue Corporation
• Hollister Incorporated
• ScarHeal, Inc.
• Heraeus Medical, LLC
• BSN medical GmbH
• Cohera Medical, Inc.
• Dermabond (Ethicon)
• Chase Medical, LLC

The competitive landscape of the topical skin adhesive market is characterized by several key players striving for market dominance through innovation, strategic partnerships, and acquisitions. Companies are increasingly focusing on research and development to enhance their product offerings, leading to the introduction of advanced adhesive formulations that address specific clinical needs. Additionally, many leading firms are expanding their geographical presence to tap into emerging markets, thereby increasing their customer base and revenue potential. The emphasis on quality, safety, and clinician education further elevates the competitive dynamics within the market.

3M Company is one of the most prominent players in the topical skin adhesive market, known for its diverse range of medical adhesive products. The company's innovation-driven approach has led to the development of advanced cyanoacrylate-based adhesives that cater to both surgical and cosmetic applications. With a strong emphasis on research and development, 3M continues to explore new adhesive technologies to enhance patient outcomes. Baxter International Inc. is another key competitor, specializing in fibrin-based adhesives that play a significant role in surgical wound closure and hemostasis. The company's commitment to quality and safety positions it favorably in the competitive landscape, allowing it to maintain strong relationships with healthcare providers.

Ethicon, a subsidiary of Johnson & Johnson, stands out as a leading manufacturer of surgical adhesives, particularly in the area of cyanoacrylate adhesives. With a long-standing reputation in the medical field, Ethicon has established a strong market presence through its innovative products and extensive portfolio. The company invests significantly in clinical research to support the efficacy and safety of its adhesives, ensuring the trust of healthcare professionals. Medtronic plc is another influential player, known for its comprehensive range of wound closure solutions, including topical adhesives. The company's focus on minimally invasive technologies and patient-centric solutions drives its competitive edge in the market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 3M Company
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Medtronic plc
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 ScarHeal, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 BSN medical GmbH
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Chase Medical, LLC
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Smith & Nephew plc
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Dermabond (Ethicon)
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Cohera Medical, Inc.
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Heraeus Medical, LLC
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 SuperGlue Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Hollister Incorporated
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Adhezion Biomedical, LLC
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Baxter International Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 West Pharmaceutical Services, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Ethicon, Inc. (subsidiary of Johnson & Johnson)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Topical Skin Adhesive Sales Market, By Application
    • 6.1.1 Surgical Procedures
    • 6.1.2 Trauma Wound Care
    • 6.1.3 Burn Injury Care
    • 6.1.4 Others
  • 6.2 Topical Skin Adhesive Sales Market, By Product Type
    • 6.2.1 Cyanoacrylate-based Adhesives
    • 6.2.2 Fibrin-based Adhesives
    • 6.2.3 Collagen-based Adhesives
    • 6.2.4 Albumin-based Adhesives
    • 6.2.5 Gelatin-based Adhesives
  • 6.3 Topical Skin Adhesive Sales Market, By Ingredient Type
    • 6.3.1 2-Octyl Cyanoacrylate
    • 6.3.2 N-Butyl Cyanoacrylate
    • 6.3.3 Human Fibrinogen
    • 6.3.4 Human Thrombin
    • 6.3.5 Collagen
  • 6.4 Topical Skin Adhesive Sales Market, By Distribution Channel
    • 6.4.1 Hospitals
    • 6.4.2 Specialty Clinics
    • 6.4.3 Ambulatory Surgical Centers
    • 6.4.4 Retail Pharmacies

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Topical Skin Adhesive Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Topical Skin Adhesive Sales market is categorized based on

By Product Type

• Cyanoacrylate-based Adhesives
• Fibrin-based Adhesives
• Collagen-based Adhesives
• Albumin-based Adhesives
• Gelatin-based Adhesives

By Application

• Surgical Procedures
• Trauma Wound Care
• Burn Injury Care
• Others

By Distribution Channel

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Retail Pharmacies

By Ingredient Type

• 2-Octyl Cyanoacrylate
• N-Butyl Cyanoacrylate
• Human Fibrinogen
• Human Thrombin
• Collagen

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• 3M Company
• Baxter International Inc.
• Ethicon, Inc. (subsidiary of Johnson & Johnson)
• Medtronic plc
• West Pharmaceutical Services, Inc.
• Adhezion Biomedical, LLC
• Smith & Nephew plc
• SuperGlue Corporation
• Hollister Incorporated
• ScarHeal, Inc.
• Heraeus Medical, LLC
• BSN medical GmbH
• Cohera Medical, Inc.
• Dermabond (Ethicon)
• Chase Medical, LLC